Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Immunocore Holdings Q2 EPS $(1.04)

Immunocore Holdings (NASDAQ:IMCR) reported quarterly losses of $(1.04) per share.

August 11, 2021

1 minute read

Immunocore Holdings (NASDAQ:IMCR) reported quarterly losses of $(1.04) per share.

Goldman Sachs Downgrades Revolution Medicines to Neutral, Lowers Price Target to $27

Today, 3:25 AM

Goldman Sachs analyst Chris Shibutani downgrades Revolution Medicines (NASDAQ:RVMD) from Buy to Neutral and lowers the price target from $49 to $27.

Today, 3:25 AM

United Therapeutics Corporation (NASDAQ: UTHR) today announced an update on the U.S.

Today, 3:25 AM

Credit Suisse analyst Toby Ogg initiates coverage on SAP (NYSE:SAP) with a Outperform rating.

Today, 3:25 AM

The